Stay updated on Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision notes show a new revision entry v3.3.3 added and older entries v3.3.2 removed from the record history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-23T08:33:39.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.3.1 to v3.3.2 on the Record History page, with no observed changes to study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T15:53:25.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page history now shows a new revision entry labeled v3.3.1, replacing the previous v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T12:10:47.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    Removed a site-wide notice about government funding and operating status from the page. The notice was not specific to the trial record contents or data integrity. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-17T06:17:58.000Z thumbnail image
  7. Check
    55 days ago
    Change Detected
    Summary
    The Old and New screenshots show the same historical versions list with no added or removed entries; the change appears to be a minor layout/visual adjustment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T00:52:10.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Summary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.
    Difference
    10%
    Check dated 2025-10-05T07:41:04.000Z thumbnail image

Stay in the know with updates to Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Talimogene & Pembrolizumab Combo in Melanoma Clinical Trial page.